Free Cash Flow Chart

View Free Cash Flow for GRFS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Chart
Start Trial

Historical Free Cash Flow Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 738.77M
March 31, 2026 680.05M
December 31, 2025 706.97M
September 30, 2025 774.80M
June 30, 2025 758.23M
March 31, 2025 873.35M
December 31, 2024 578.27M
September 30, 2024 223.35M
June 30, 2024 78.84M
March 31, 2024
December 31, 2023
September 30, 2023
June 30, 2023
March 31, 2023
March 31, 2021 985.10M
December 31, 2020 864.02M
September 30, 2020 748.92M
June 30, 2020 613.20M
March 31, 2020 484.09M
December 31, 2019 180.31M
September 30, 2019 361.09M
June 30, 2019 328.14M
March 31, 2019 186.63M
December 31, 2018 510.55M
September 30, 2018 432.92M
Date Value
June 30, 2018 478.83M
March 31, 2018 541.93M
December 31, 2017 585.14M
September 30, 2017 493.39M
June 30, 2017 494.33M
March 31, 2017 376.93M
December 31, 2016 288.26M
September 30, 2016 462.54M
June 30, 2016 439.82M
March 31, 2016 555.37M
December 31, 2015 200.45M
September 30, 2015 240.04M
June 30, 2015 371.34M
March 31, 2015 456.28M
December 31, 2014 917.75M
September 30, 2014 838.31M
June 30, 2014 632.35M
March 31, 2014 579.49M
December 31, 2013 556.49M
September 30, 2013 471.75M
June 30, 2013 538.62M
March 31, 2013 478.14M
December 31, 2012 437.99M
September 30, 2012 437.66M
June 30, 2012 310.85M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
argenx SE 1.090B
Evaxion AS --
Autolus Therapeutics Plc -240.12M
Pharma Mar SA 62.89M
Oryzon Genomics SA --